Related Experiment Video
Updated: Sep 30, 2025

07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
239
Discovery and repurposing of artemisinin
Qiaoli Shi1, Fei Xia1, Qixin Wang1
1Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Frontiers of Medicine
|March 15, 2022
Summary
Artemisinin, derived from traditional Chinese medicine (TCM), revolutionized malaria treatment. Its success highlights TCM
Area of Science:
- Pharmacology
- Infectious Diseases
- Traditional Chinese Medicine (TCM)
Background:
- Malaria remains a significant global health threat, affecting millions worldwide.
- Artemisinin, discovered from TCM, transformed malaria treatment, offering high potency and low toxicity.
- Its use has been crucial in combating drug-resistant malaria parasites and aiding eradication efforts.
Purpose of the Study:
- To review the discovery of artemisinin and its unique development path.
- To explore the potential repurposing of artemisinin and its derivatives for other diseases.
- To discuss the broader implications of the artemisinin story for modern TCM development.
Main Methods:
- Literature review of artemisinin's discovery and historical context.
- Analysis of artemisinin's efficacy against malaria and drug-resistant strains.
- Exploration of current research on artemisinin's application in other therapeutic areas.
Main Results:
- Artemisinin's discovery represents a significant advancement, contrasting with conventional Western drug development.
- Artemisinin and its derivatives show promise for treating cancer, inflammation, and viral infections like COVID-19.
- The success of artemisinin underscores the potential of TCM in modern medicine.
Conclusions:
- The artemisinin story provides valuable insights for the future development of TCM.
- TCM holds significant potential to contribute further to global healthcare in the 21st century.
- Artemisinin serves as a precedent for leveraging traditional knowledge in drug discovery.

